Idiopathic myelofibrosis complicated by chronic lymphatic leukaemiaKAUFMAN, S; IUCLEA, S; REIF, R et al.Clinical and laboratory haematology. 1987, Vol 9, Num 1, pp 81-84, issn 0141-9854Article

A fluorescent dye which recognizes mature peripheral erythrocytes of myeloproliferative disordersREED, J. A; GREEN, R; YAMADA, Y et al.Cell biology international reports. 1987, Vol 11, Num 1, pp 55-62, issn 0309-1651Article

Case report osteolytic lesions in idiopathic myelofibrosisGRUBER, A; ÖSBY, E.Medical oncology and tumor pharmacotherapy. 1987, Vol 4, Num 2, pp 107-109, issn 0736-0118Article

Increased vascularity of bone marrow in myelofibrosisCHARBORD, P.British journal of haematology. 1986, Vol 62, Num 3, pp 595-596, issn 0007-1048Article

Diagnosis of storage pool deficiency by determination of diadenosine 5', 5″'―P¹, P⁴-tetraphosphate in whole bloodFLODGAARD, H; ZAMECNIK, P. C; MEYERS, K et al.Thrombosis research. 1986, Vol 41, Num 3, pp 345-351, issn 0049-3848Article

Myeloproliferative disorder during the course of multiple myelomaECONOMOPOULOS, T; STATHAKIS, N; PAPAGEORGIOU, E et al.Acta haematologica. 1986, Vol 76, Num 2, pp 176-177, issn 0001-5792Article

Staging of idiopathic myelofibrosisGUSTAVSSON, P; HOLM, J; WAHLIN, A et al.Acta medica Scandinavica. 1985, Vol 218, Num 5, pp 487-491, issn 0001-6101Article

Massive splenomegaly in myeloproliferative disorders treated by splenic artery infusion of cytarabineSLOCOMBE, G. W; TURNER, M. J; NEWLAND, A. C et al.Clinical and laboratory haematology. 1986, Vol 8, Num 1, pp 9-19, issn 0141-9854Article

Treatment of polycythemia vera with hydroxyureaSHARON, R; TATARSKY, I; BEN-ARIEH, Y et al.Cancer. 1986, Vol 57, Num 4, pp 718-720, issn 0008-543XArticle

Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndromeBUDDE, U; DENT, J. A; BERKOWITZ, S. D et al.Blood. 1986, Vol 68, Num 6, pp 1213-1217, issn 0006-4971Article

The effect of hydroxyurea on hemoglobin F in patients with myeloproliferative syndromesALTER, B. P; GILBERT, H. S.Blood. 1985, Vol 66, Num 2, pp 373-379, issn 0006-4971Article

Myeloproliferative disordersMURRAY, Jim.Clinical medicine. 2005, Vol 5, Num 4, pp 328-332, issn 1470-2118, 5 p.Article

Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with timeBAKER, R. I; MANOHARAN, A.European journal of haematology. 1988, Vol 40, Num 3, pp 267-272, issn 0902-4441Article

Amyloidosis complicating idiopathic myelofibrosisAKIKUSA, B; KOMATSU, T; KONDO, Y et al.Archives of pathology & laboratory medicine (1976). 1987, Vol 111, Num 6, pp 525-529, issn 0363-0153Article

Ultrastructure of sinusoids in patients with agnogenic myeloid metaplasiaBIOULAC-SAGE, P; ROUX, D; QUINTON, A et al.Journal of submicroscopic cytology. 1986, Vol 18, Num 4, pp 815-821, issn 0022-4782Article

Transient myeloproliferative disorderMOIZ, Bushra; SHAFLQ, Maria.Blood. 2012, Vol 120, Num 24, issn 0006-4971, p. 4672Article

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseAGARWAL, Anupriya; BUMM, Thomas G. P; DEININGER, Michael W et al.Blood. 2008, Vol 112, Num 5, pp 1960-1970, issn 0006-4971, 11 p.Article

Genetics of myeloid malignancies : Pathogenetic and clinical implicationsFROHLING, Stefan; SCHOLL, Claudia; GILILAND, D. Gary et al.Journal of clinical oncology. 2005, Vol 23, Num 26, pp 6285-6295, issn 0732-183X, 11 p.Article

Hématopoièse cutanée et myélofibrose = Cutaneous hematopoiesis and myelofibrosisPIERARD, G.-E.Annales de pathologie (Paris). 1987, Vol 7, Num 1, pp 73-75, issn 0242-6498Article

Spontaneous hemoperitoneum in two patients with myeloproliferative disordersSTORNIOLO, A. M; FITZGERALD, D. B; ROWE, J. M et al.American journal of hematology. 1987, Vol 24, Num 4, pp 433-435, issn 0361-8609Article

Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseasesGROSSI, A; VANNUCCHI, A. M; RAFANELLI, D et al.Thrombosis research. 1986, Vol 43, Num 3, pp 367-374, issn 0049-3848Article

Multilineage expression of haemopoietic precursors with an abnormal clone in idiopathic myelofibrosisSATO, Y; SUDA, T; SUDA, J et al.British journal of haematology. 1986, Vol 64, Num 4, pp 657-667, issn 0007-1048Article

Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosisSACCHI, S; CURCI, G; PICCININI, L et al.Scandinavian journal of clinical & laboratory investigation. 1986, Vol 46, Num 2, pp 163-166, issn 0036-5513Article

Myélofibrose aiguë maligne: une entité autonome = Acute malignant myelofibrosis. A separate entityLASSERRE, M; DUPLAY, H; ETTORE, P et al.La Semaine des hôpitaux de Paris. 1986, Vol 62, Num 24, pp 1807-1812, issn 0037-1777Article

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemiaWINTER, J. N; VARIAKOJIS, D; GAYNOR, E. R et al.Cancer. 1985, Vol 56, Num 3, pp 443-449, issn 0008-543XArticle